A Phase II, Randomized Study on an Investigational DTPw-HBV/Hib-MenAC Conjugate Vaccine Administered to Infants in Northern Ghana
Figure 2
Reverse cumulative curves for antibody concentration/titre, 1 month after the third dose of vaccine (Primary ATP cohort for immunogenicity).
Footnote: HibMenAC = DTPw-HBV/Hib-MenAC; Control = DTPw-HBV/Hib.